Oligonucleotide API Market - Top Companies and Manufacturers

Companies Dominating the Oligonucleotide API Landscape

Ionis Pharmaceuticals, Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis

Jazz Pharmaceuticals plc
BIOGEN INC.
Sarepta Therapeutics, Inc.
Alnylam Pharmaceuticals, Inc.
Corden Pharma International GmbH
Nitto Denko Avecia, Inc.
Merck KGaA
Ajinomoto Co., Inc.
Kaneka Eurogentec S.A.

Browse Key Market Insights with Data Illustration:

Oligonucleotide API Market Size, Growth Trends 2036

In the News

Ionis Pharmaceuticals, Inc. in collaboration with Biogen Inc., has announced the results of the investigation of the use of antisense oligonucleotide (ASO) for people with C9orf72-associated amyotrophic lateral sclerosis (ALS).
Jazz Pharmaceuticals plc has announced that its Zepzelca (Lurbinectedin) has been approved by the U.S. Food and Drug Administration(FDA), for treating adult patients with metastatic small cell lung cancer (SCLC) with disease progression on or after platinum-based chemotherapy.

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of oligonucleotide api is assessed at USD 2.4 Billion.

The oligonucleotide api market size was over USD 2.19 Billion in 2023 and is anticipated to reach USD 7.21 Billion by the end of 2036, growing at around 9.6% CAGR during the forecast period i.e., between 2024-2036. Globally rising prevalence of cancer and neurodegenerative diseases, growth in percentage of API manufacturing facilities, and growing expenditures on healthcare throughout the world are the major factors driving the market growth.

North America is expected to hold majority industry share by 2036, attributed majorly to the increased healthcare spending, along with enhanced healthcare facilities in the region.

Ionis Pharmaceuticals, Inc, .Jazz Pharmaceuticals plc, BIOGEN INC., Sarepta Therapeutics, Inc., Alnylam Pharmaceuticals, Inc., Corden Pharma International GmbH, Nitto Denko Avecia, Inc., Merck KGaA, Ajinomoto Co., Inc., Kaneka Eurogentec S.A.

Oligonucleotide API Market - Top Companies and Manufacturers

Companies Dominating the Oligonucleotide API Landscape

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

How much is the oligonucleotide api market worth?

Why is the demand for oligonucleotide api growing?

Which region dominated the majority of oligonucleotide api industry share?

Who are the top oligonucleotide api companies?